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Introduction
Sonography, in addition to mammography, has 
become a standard breast imaging tool in the past 
couple of decades because of significant improvements 
in equipment as well as clinical experience resulting 
in improved accuracy of assessing breast lesions 
(Costantini et al., 2006; Giess et al., 2012). 
It is widely available, easily tolerated and free 
from adverse effects of radiation or contrast medium 
(Chae et al., 2016).
Earlier, ultrasound was predominantly employed in 
differentiating between cystic and solid breast masses 
however its role has now expanded from simply 
characterizing the internal contents of the mass to 
differentiating between benign and malignant solid 
masses. It may also be the screening tool for young 
women or those with dense breasts (Costantini et 
al., 2006; Kim et al., 2008; Shin et al., 2015) and an 
important adjunct to mammography in older patients 
as well as a primary imaging tool for women younger 
than 40 years who present with a palpable breast mass 
(Constance et al., 2014).
As a result, the Breast Imaging Reporting and 
Data System (BI-RADS) lexicon, initially developed 
for mammography was expanded to include a breast 
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ultrasound lexicon. The American College of Radiology 
released the lexicon for breast US in 2003. This not only 
provides and facilitates better communication between 
the radiologists and clinicians but also guarantees 
uniformity to recommendations (ACR, 2003).
The abnormalities detected on ultrasound are 
categorized into six categories. A lump which corresponds 
to a clear benign finding, that is BIRADS 2 on ultrasound, 
such as a simple cyst, non-pathologic lymph node, lipoma, 
sebaceous cyst, clustered microcysts, or duct ectasia, can 
safely undergo clinical follow-up without short-interval 
imaging follow-up, needle aspiration, or biopsy. 
The lesions categorized as BIRADS 3 are recommended 
an initial short follow up at 6 months followed by 12 
months and 24 months follow up to establish stability.
Several studies have shown that an oval or gently 
lobulated shape, circumscribed margin, and parallel 
orientation on ultrasonography (US) are useful features 
for differentiating benign solid masses from malignant 
lesions, and that it is reasonable to categorize lesions 
with these characteristics as BI-RADS 3, probably 
benign (Stavros et al., 1995; Rahbar et al., 1999; Graf et 
al., 2004; Hong et al, 2005; Costantini et al., 2006; Graf 
et al., 2007; Chala et al., 2007; Leung and Sickles 2007; 
Kim et al., 2008).
The ACR BI-RADS manual 2003, 4th edition, 
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recommended short-term follow-up only for non-palpable 
findings however as the rates of malignancy in palpable 
probably benign lesions are not significantly different 
from those of non-palpable probably benign lesions 
(Harvey et al., 2009; Shin et al., 2015), the current 
ACR manual, 2013, 5th edition supports the same 
recommendation for both (D’Orsi et al., 2013).
The malignancy rate of probably benign breast lesions 
on US ranges between 0% and 0.8% (Raza et al., 2008; 
Moon et al., 2010).
These results support the rationale that a short interval 
follow-up is an acceptable alternative to biopsy.
Despite many studies recommending follow up to 
be safe for BI-RADS 3 solid lesions, the practice at our 
institute is inconsistent. The contributing factors may be 
the level of experience or expertise of the radiologist and 
the confidence of the referring surgeon on her along with 
discrepancy in the clinical features. Our hospital is the 
largest private tertiary care center in the country and many 
patients seeking consultation come from outside the city. 
As there is a fear that they might not return for follow up 
and also to relieve their anxiety biopsy is often performed 
on BIRADS 3 lesions. This however has significant 
financial implications in our set up as the patient pays 
for the biopsy out of her own pocket. The outcome of 
such patients as well as those returning for follow up 
has not been previously assessed locally. This formed 
the rationale for performing this study. We intend to 
examine the negative predictive value of US for breast 
masses with probably benign morphology and to assess 
whether follow-up US may be an acceptable alternative to 
immediate biopsy.
Materials and Methods
Study design and inclusion criteria
The study was conducted at the Radiology 
Department of Aga Khan University Hospital, Karachi. 
This retrospective study was approved by the institutional 
review board and informed consent was waived. 
Ultrasound report of all consecutive patients undergoing 
breast ultrasound examination from January 2014 to 
December 2015 were reviewed and those patients who 
had initial breast ultrasound in this period categorized 
as BI-RADS 3 according to ACR ultrasound BIRADS 
lexicon were identified (Figure 1). These were 141 in 
number. Out of these, 101 patients were excluded due to 
either inadequate follow up (n= 62), appeared as cysts/duct 
on follow up ultrasound (n=12), had features suggesting 
mastitis/abscess (n=21), intramammary lymph nodes (n=3), 
galactocele (n=1) and scar/seroma (n=2). The remaining 40 
patients with 157 masses constituted the study population 
(mean age, 31.3 years; age range, 20-56 years). These 
included patients/lesions with adequate follow up for 2 
years, less than 2 years follow up with downgrading to 
BIRADS 2 category or those who underwent biopsy with 
histopathological confirmation.
Imaging and interpretation
Two radiologists, with experience of 10 and 13 years 
respectively in breast imaging, reviewed the sonographic 
images and reports and extracted patient’s demographics. 
Lesions included in imaging surveillance were considered 
benign if remained stable for at least 24 months, were 
decreased in size on follow up imaging or had a benign 
tissue diagnosis in the larger lesion in cases where there 
were multiple lesions in the same patient. Sonographic 
examination was performed on Aplio 400 and Zario 
200 Ultrasound machines with 7.5 MHz linear array 
transducer. All sonographic examinations were performed 
or supervised by attending radiologists with 5-15 years of 
experience in breast imaging. 
The US categorization was based on ACR BI-RADS 
(Table 1) and the criteria established in the study by Stavros 
et al., (1995). The features on the basis of which the masses 
were categorized as BI-RADS 3 included oval or gently 
lobulated shape, circumscribed margins, long axis parallel 
to the skin, predominantly hypoechoic homogeneous 
internal echotexture, and no overt features of malignancy 
which are:  irregular shape, microlobulations, angular or 
spiculated margins, and heterogeneous echotexture with 
posterior acoustic shadowing.
The number of lesions, side, location (quadrant), and 
maximum diameter was recorded.
Standard imaging surveillance protocol for probably 
benign lesion was followed which includes 6 months, 12 
months and 24 months. The duration of follow up ranged 
from 6 to 36 months.
Biopsy
Percutaneous biopsy was performed in 17 lesions 
due to either change on imaging surveillance or 
physician’s preference. None of the patient underwent 
FNA. Core biopsies were performed with 14- gauge needle 
using automated gun and four to six cores were obtained to 
ensure adequacy of the sample.
Statistical analysis 
Statistical analysis was performed using SPSS 
statistical software version 22 for Windows.
False negative rate and negative predictive value 
(NPV) were calculated. 
Results
A total of 157 lesions in 40 patients constituted the 
study population. The mean patient age was 31.3 years 
(range, 20-56 years). Out of these, 157 lesions 138 (88%) 
occurred in women less than 40 years and 19 lesions (12%) 
in patients 40 years or above (Table 2).
The mean les ion  d iameter  was  13 .4  mm 
(range, 3-46 mm). Majority of the lesions, 125 (79%) 
were non palpable. Slightly more lesions, 81 (51.6%) 
occurred in the right breast.
Based on location, retro areolar region was the 
least common site of involvement, 4 out of 157 (2.5%) 
while upper outer quadrant the most common site of 
involvement, seen in 60 (38.2%) lesions. 
One hundred and sixteen lesions (74%) were oval in 
shape while the rest were non oval. 
About 50% of the lesions showed lobulations. 
Majority of the lesions, 117 (75%) lesions had 
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Twenty five lesions had follow-up surveillance for less 
than 24 months (range; 6 months to 23 months). Out of 
these 25 lesions, eleven lesions occurred in those patients 
who had multiple lesions and the largest had already 
been proved benign on biopsy.  One of the lesions 
a homogeneous echotexture. Most of the lesions 147 
(94%) showed a parallel orientation to the skin. 
Seventeen out of total 157 lesions underwent tissue 
diagnosis with no invasive breast cancer (Figure 2). 
Out of these 17 lesions, 5 had shown increase on follow 
up imaging while the rest 12 were biopsied on surgeon’s 
discretion.
The histopathology was benign fibro epithelial lesion 
in 16 patients and stromal sclerosis in 1 patient.
115 lesions out of remaining 140 were stable for 24 
or more months and were considered benign (Figure 3). 
Assessment incomplete
     Category 0: need additional imaging evaluation
Assessment Complete (final categories)
     Category 1: negative
     Category 2: benign finding
     Category 3: probably benign; short interval follow up suggested
     Category 4: suspicious abnormality; biopsy should be considered
     Category 5: highly suggestive of malignancy; appropriate action should be taken
     Category 6: known biopsy proven malignancy
Table 1. American College of Radiology BIRADS Classification; Final Assessment Categories
Figure 1. Flow Chart of the Study Population
Parameter Number of lesions
Age
     <40 years 138
     >40 years 19
Multiplicity
     Single 8
     Multiple 149
Palpability
     Palpable 32
     Non palpable 125
Side involved
     Right 81
     Left 76
Lesion size
     <10mm 62
     >10mm 95
Table 2. Demographics of the Study Population and 
the Lesion Characteristics
Figure 2. A 21-year-old Woman with a Palpable Mass in 
the Upper Inner Quadrant of Right Breast. Ultrasound 
shows a 28 mm, oval, circumscribed, hypoechoic mass 
categorized as probably benign. Fibroadenoma was 
diagnosed by ultrasound-guided 14-gauge core needle 
biopsy.
A=28mm, B=11mm
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decreased in size on follow up and hence was deemed 
benign. The reason for shorter follow up in remaining 
13 lesions was that the repeat ultrasound was done by 
a different radiologist who based on her assessment did 
not recommend continued imaging. 
Discussion
Ultrasound has proved to be a useful tool for 
evaluation of both palpable and non-palpable breast 
masses as it not only differentiates between solid and 
cystic lesions but also helps in characterizing the solid 
breast masses. However as the ultrasound is operator 
dependent, the interpretation as well as use of BI-RADS 
3 category recommendation is variable. This is also true 
for follow up ultrasound as the second examiner may 
have different level of training and experience along 
with challenging technical factors such as breast size and 
lesion position which may alter the interpretation and 
hence assessment category (Raza et al., 2008). Thirteen of 
the lesions in our study were downgraded to BIRADS 
2 category by the radiologist performing the follow up 
ultrasound. A very good agreement has been reported 
for lesion location and size while the margin assessment, 
echogenicity, and final assessment have lower agreement 
(Berg et al., 2006; Lazarus et al., 2006). 
Despite these variations, the benign sonographic 
features have been reported to have high negative 
predictive value for malignancy ranging from 96 to 
100% (Stavros et al., 1995; Skanne and Engedal, 1998; 
Paulinelli et al., 2005; Mainiero et al., 2005; Graf et 
al., 2007; Kim et al., 2008). Some of these studies have 
been done on palpable masses while some included only 
non-palpable lesions. The palpability of a mass does not 
always indicate a new development or a growth in the 
lesion. The lesion may be palpable due to its superficial 
nature or may catch patient attention secondary to newly 
initiated breast examination and sometimes even due to 
trauma. Our study included patients with both palpable 
and non-palpable lesions however the majority of 
the lesions were non-palpable (79%). The reason for less 
number of palpable lesions could be the fact the reporting 
radiologists may have a variable approach to palpable 
solid lesions, some recommending tissue diagnosis rather 
than surveillance and categorizing them as BIRADS 4 
lesions regardless of benign imaging features. None of 
the biopsied lesion in our study showed malignancy, all 
were benign, with 94% being fibroadenomas. Among 
the patients undergoing imaging surveillance, all were 
stable and did not show any overt features of malignancy 
later during follow up. Hence our results showed 100% 
negative predictive value of ultrasound for breast lesions 
categorized as BI-RADS 3.
These results are comparable to the study done by 
Patterson et al (2014) which showed no cancer in BIRADS 
3 group on biopsy and the lesions showed stability on 
follow up imaging. The study done by Raza et al., (2008), 
although did show cancer in the BIRADS 3 masses, the 
number was very small (0.8%) and all were diagnosed 
on initial 6-month follow-up examination, also they were 
less than 1 cm in size and without positive axillary nodes. 
The minimal delay in diagnosis had no detrimental effect 
on the patients. Park et al., (2008) also showed a very 
high negative predictive value (99.4%) of ultrasound in 
BIRADS 3 lesions.
A factor to keep in consideration regarding follow up 
recommendation is patient compliance. A large of patients 
in our study were initially excluded (62 out of 141) as 
they failed to return for follow up and did not undergo 
the recommended imaging surveillance. Biopsy may 
therefore be a safe alternative in selected BI-RADS 3 
cases where there is a strong likelihood that the patient 
might not return.
There were a few limitations in our study. A significant 
number of patients with BI-RADS 3 lesions did not 
come back for adequate follow up resulting in decrease 
in sample size. This may be because of cost issues as our 
hospital is a private tertiary care center and many patients 
do not have the resources to return for follow up and often 
continue care at their local facilities. Secondly, not all 
patients had complete 24 months follow up. In several 
of these patients the initial and follow up ultrasound 
examinations were performed by different examiners 
and the second examiner did not recommend continued 
imaging. This highlights the fact that assuring the same 
examiner for follow up may ensure adherence to the 
recommended imaging protocol for BI-RADS 3 lesions. 
Third, in patients with multiple lesions, since the largest 
lesion proved benign on histopathology the other smaller 
lesions were also deemed benign and follow up was 
discontinued.
To conclude, ultrasound has a very high negative 
predictive value for breast lesions with probably benign 
morphology. We therefore suggest follow up as an 
appropriate option to immediate biopsy of such lesions 
keeping in mind that non-compliance with surveillance 
may be a potential problem. A study with larger number of 
patients may further validate this study.
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